scispace - formally typeset
J

John D. Ginn

Researcher at Boehringer Ingelheim

Publications -  26
Citations -  499

John D. Ginn is an academic researcher from Boehringer Ingelheim. The author has contributed to research in topics: Cycloaddition & Sulfonium. The author has an hindex of 13, co-authored 23 publications receiving 475 citations. Previous affiliations of John D. Ginn include Emory University.

Papers
More filters
Journal ArticleDOI

Discovery of potent and selective PKC-θ inhibitors

TL;DR: In this article, an uHTS campaign was performed to identify selective inhibitors of PKC-theta and triaging of the hit set based on selectivity and historical analysis led to the identification of 2,4-diamino-5-nitropyrimidines as potent and selective PKC theta inhibitors.
Journal ArticleDOI

Total Synthesis of (±)-Stenine Using the IMDAF Cycloaddition of a 2-Methylthio-5-amido-substituted Furan

TL;DR: The intramolecular [4 + 2]-cycloaddition of a 2-methylthio-5-amidofuran was used to create the azepinoindole skeleton present in the Stemona alkaloid stenine.
Journal ArticleDOI

Studies on the synthesis of (+/-)-stenine: a combined intramolecular [4 + 2]-cycloaddition/rearrangement cascade.

TL;DR: The eventual synthesis of (+/-)-stenine was carried out by an intramolecular Diels-Alder reaction of a 2-amido-5-methylthio-substituted furan containing a trans-pent-3-enoic acid methyl ester side chain in order to create the desired azepinoindole skeleton.
Journal ArticleDOI

Synthesis of azapolycyclic systems via the intramolecular [4 + 2] cycloaddition chemistry of 2-(alkylthio)-5-amidofurans.

TL;DR: A computational study was undertaken to identify structural features that promote the IMDAF reaction and results indicate that the incorporation of an amide carbonyl as part of the tether system works to place the dienophile in closer proximity to the furan ring, thereby lowering the activation energy needed to reach the transition state.
Journal ArticleDOI

Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidines.

TL;DR: The authors' efforts focused on improving the ROCK potency of this isoquinolone class of inhibitors which led to the identification of pyrrolidine 32 which demonstrated a 10-fold improvement in aortic ring (AR) potency over 2.